Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

4.00
Delayed Data
As of Jul 31
 +0.05 / +1.27%
Today’s Change
3.11
Today|||52-Week Range
9.37
-33.99%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Turner Heather D
General Counsel, Secretary & Vice President
Sale9/22/2014300,000$4.47$1.3M-11.31%
Turner Heather D
General Counsel, Secretary & Vice President
Buy9/22/2014300,000$1.66$498.0K-11.31%
Booth Mark D
Chief Commercial Officer
Sale2/26/201550,000$5.68$284.0K-31.86%
Narachi Michael A
President & Chief Executive Officer
Buy9/15/201450,000$4.78$239.0K-18.03%
Bock Louis C
Director
Buy11/12/201427,052$5.57$150.7K-31.51%
Turner Heather D
General Counsel & Senior Vice President
Sale11/24/201424,006$5.77$138.5K-31.86%
Turner Heather D
General Counsel & Senior Vice President
Sale12/02/201422,643$6.00$135.9K-33.55%
Booth Mark D
Chief Commercial Officer
Buy2/26/201550,000$1.66$83.0K-31.86%
Turner Heather D
General Counsel & Senior Vice President
Sale11/25/20147,382$6.00$44.3K-30.80%
Turner Heather D
General Counsel & Senior Vice President
Buy11/24/201424,006$1.66$39.8K-31.86%
Page of 2